Working with the FDA: Medical Devices and Regulatory Touchpoints

This webinar discusses practical and strategic approaches to interacting with FDA during medical device development.

Questions? Contact Us
Scroll Down Arrow


About this Webinar

Medical device manufacturers and clinical investigators are responsible for conducting investigations to demonstrate safety and effectiveness of Class III devices and those on the Class II/III cusp. To be successful, sponsors and investigators need to skillfully approach the FDA as a collaborative partner. There are several opportunities to work with the FDA, from pre-submission correspondence through marketing application.

This webinar examines the regulatory touchpoints with the FDA during medical device development, with an eye toward uncovering those practical strategies that a device sponsor or investigator can take to streamline the path to market clearance or approval.

Webinar Demo:

Release Date: June 9, 2022

Language Availability: English

Suggested Audiences: Compliance Professionals, Faculty and Post-Docs, General Counsel, Principal Investigators, Research Administrators, Sponsors

Organizational Subscription Price: $300 per year/per site or included as part of an annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person


Webinar Content

Working with the FDA: Medical Devices and Regulatory Touchpoints

Presented by: Robert Michalik, JD, RAC - RegulatoryPro Consulting

Learning Objectives:

  • Examine the legal and regulatory requirements for executing a successful clinical investigation of a medical device.
  • Explore the practical aspects of clinical development and FDA compliance for medical devices, including FDA touchpoints.
  • Discuss Breakthrough Device designation criteria as a regulatory strategy.

Recommended Use: Required
ID (Language): 20673 (English)


Learn More

Your Name(Required)
I'd Like To Receive Emails From CITI Program
This field is for validation purposes and should be left unchanged.